Mirador Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.95M | Buy |
11,872
+51
| +0.4% | +$24.5K | 0.73% | 34 |
|
|
2026
Q1 | $5.81M | Buy |
11,821
+77
| +0.7% | +$41.8K | 0.82% | 29 |
|
|
2025
Q4 | $6.81M | Buy |
11,744
+504
| +4% | +$285K | 0.93% | 23 |
|
|
2025
Q3 | $5.45M | Buy |
11,240
+2,253
| +25% | +$1.05M | 0.77% | 33 |
|
|
2025
Q2 | $3.64M | Buy |
8,987
+158
| +2% | +$66.1K | 0.59% | 39 |
|
|
2025
Q1 | $4.39M | Buy |
8,829
+280
| +3% | +$152K | 0.77% | 34 |
|
|
2024
Q4 | $4.45M | Buy |
8,549
+58
| +0.7% | +$31.9K | 0.81% | 32 |
|
|
2024
Q3 | $5.25M | Buy |
8,491
+117
| +1% | +$69.3K | 0.95% | 26 |
|
|
2024
Q2 | $4.63M | Buy |
8,374
+136
| +2% | +$77.9K | 0.87% | 30 |
|
|
2024
Q1 | $4.79M | Sell |
8,238
-347
| -4% | -$195K | 0.91% | 26 |
|
|
2023
Q4 | $4.56M | Sell |
8,585
-5,724
| -40% | -$2.77M | 0.96% | 25 |
|
|
2023
Q3 | $7.24M | Buy |
14,309
+172
| +1% | +$91.7K | 1.65% | 13 |
|
|
2023
Q2 | $7.38M | Buy |
14,137
+106
| +0.8% | +$57.2K | 1.75% | 10 |
|
|
2023
Q1 | $8.09M | Sell |
14,031
-929
| -6% | -$524K | 1.92% | 12 |
|
|
2022
Q4 | $8.24M | Sell |
14,960
-156
| -1% | -$82.7K | 1.95% | 10 |
|
|
2022
Q3 | $7.67M | Buy |
15,116
+80
| +0.5% | +$44.8K | 1.85% | 13 |
|
|
2022
Q2 | $8.17M | Buy |
15,036
+10
| +0.1% | +$5.5K | 1.93% | 12 |
|
|
2022
Q1 | $8.88M | Buy |
15,026
+238
| +2% | +$137K | 1.8% | 12 |
|
|
2021
Q4 | $9.87M | Buy |
14,788
+472
| +3% | +$295K | 2.08% | 8 |
|
|
2021
Q3 | $8.18M | Buy |
14,316
+324
| +2% | +$178K | 1.86% | 14 |
|
|
2021
Q2 | $7.06M | Buy |
13,992
+531
| +4% | +$251K | 1.6% | 17 |
|
|
2021
Q1 | $6.14M | Buy |
13,461
+1,214
| +10% | +$579K | 1.58% | 16 |
|
|
2020
Q4 | $5.7M | Buy |
12,247
+1,704
| +16% | +$799K | 1.57% | 16 |
|
|
2020
Q3 | $4.66M | Buy |
10,543
+222
| +2% | +$91.7K | 1.45% | 21 |
|
|
2020
Q2 | $3.74M | Buy |
10,321
+140
| +1% | +$46.9K | 1.4% | 19 |
|
|
2020
Q1 | $3.41M | Buy |
10,181
+1,339
| +15% | +$422K | 1.43% | 19 |
|
|
2019
Q4 | $2.87M | Sell |
8,842
-218
| -2% | -$66.1K | 1.16% | 26 |
|
|
2019
Q3 | $2.64M | Sell |
9,060
-130
| -1% | -$37.2K | 1.18% | 25 |
|
|
2019
Q2 | $2.7M | Sell |
9,190
-196
| -2% | -$54K | 1.33% | 24 |
|
|
2019
Q1 | $2.57M | Sell |
9,386
-356
| -4% | -$88.6K | 1.39% | 23 |
|
|
2018
Q4 | $2.18M | Sell |
9,742
-451
| -4% | -$106K | 1.35% | 26 |
|
|
2018
Q3 | $2.49M | Buy |
10,193
+150
| +1% | +$34.5K | 1.22% | 25 |
|
|
2018
Q2 | $2.08M | Sell |
10,043
-170
| -2% | -$36.1K | 1.13% | 30 |
|
|
2018
Q1 | $2.15M | Sell |
10,213
-407
| -4% | -$85.4K | 1.5% | 19 |
|
|
2017
Q4 | $2.02M | Buy |
10,620
+191
| +2% | +$36.6K | 1.1% | 30 |
|
|
2017
Q3 | $2M | Buy |
10,429
+111
| +1% | +$20.1K | 1.17% | 26 |
|
|
2017
Q2 | $1.82M | Buy |
10,318
+413
| +4% | +$69.4K | 1.11% | 23 |
|
|
2017
Q1 | $1.52M | Buy |
9,905
+252
| +3% | +$38.5K | 1.11% | 28 |
|
|
2016
Q4 | $1.36M | Sell |
9,653
-440
| -4% | -$64.9K | 1.09% | 28 |
|
|
2016
Q3 | $1.6M | Sell |
10,093
-137
| -1% | -$21.1K | 1.41% | 24 |
|
|
2016
Q2 | $1.6M | Buy |
10,230
+30
| +0.3% | +$4.43K | 1.6% | 23 |
|
|
2016
Q1 | $1.44M | Buy |
+10,200
| New | +$1.37M | 1.6% | 20 |
|
Other funds holding TMO
Mirador Capital Partners's TMO Position: Q2 2026 in Review
Mirador Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 0.43% in Q2 2026, buying an estimated $24.5K and bringing the position to 11,872 shares worth $5.95M. The position accounts for 0.73% of the portfolio, ranked #34.
Mirador Capital Partners first reported a position in TMO in Q1 2016 and has held it in 42 quarters since. The position peaked at $9.87M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Mirador Capital Partners held 11,872 shares of Thermo Fisher Scientific worth $5.95M as of Q2 2026.
- Mirador Capital Partners bought 51 Thermo Fisher Scientific shares in Q2 2026, an estimated $24.5K.
- Thermo Fisher Scientific made up 0.73% of Mirador Capital Partners's portfolio in Q2 2026, its #34 holding.
- Mirador Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 42 quarters since.
- Mirador Capital Partners's Thermo Fisher Scientific position peaked at $9.87M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.